Emily Luisa Hill - Net Worth and Insider Trading
Emily Luisa Hill Net Worth
The estimated net worth of Emily Luisa Hill is at least $3 Million dollars as of 2024-11-05. Emily Luisa Hill is the CHIEF FINANCIAL OFFICER of PTC Therapeutics Inc and owns about 38,925 shares of PTC Therapeutics Inc (PTCT) stock worth over $2 Million. Emily Luisa Hill is also the CFO of Replimune Group Inc and owns about 101,057 shares of Replimune Group Inc (REPL) stock worth over $1 Million. Details can be seen in Emily Luisa Hill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Emily Luisa Hill has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Emily Luisa Hill
Emily Luisa Hill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Emily Luisa Hill owns 2 companies in total, including PTC Therapeutics Inc (PTCT) , and Replimune Group Inc (REPL) .
Click here to see the complete history of Emily Luisa Hill’s form 4 insider trades.
Insider Ownership Summary of Emily Luisa Hill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2023-03-27 | Chief Financial Officer |
| REPL | Replimune Group Inc | 2024-08-16 | Chief Financial Officer |
Emily Luisa Hill Latest Holdings Summary
Emily Luisa Hill currently owns a total of 2 stocks. Among these stocks, Emily Luisa Hill owns 38,925 shares of PTC Therapeutics Inc (PTCT) as of March 27, 2023, with a value of $2 Million and a weighting of 56.89%. Emily Luisa Hill also owns 101,057 shares of Replimune Group Inc (REPL) as of August 16, 2024, with a value of $1 Million and a weighting of 43.11%.
Latest Holdings of Emily Luisa Hill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2023-03-27 | 38,925 | 40.84 | 1,589,502 |
| REPL | Replimune Group Inc | 2024-08-16 | 101,057 | 11.92 | 1,204,599 |
Holding Weightings of Emily Luisa Hill
Emily Luisa Hill Form 4 Trading Tracker
According to the SEC Form 4 filings, Emily Luisa Hill has made a total of 17 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 7,363 shares on March 27, 2023, which brought Emily Luisa Hill around $331,335.
According to the SEC Form 4 filings, Emily Luisa Hill has made a total of 1 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Replimune Group Inc is the sale of 8,938 shares on August 16, 2024, which brought Emily Luisa Hill around $90,989.
Insider Trading History of Emily Luisa Hill
- 1
Emily Luisa Hill Trading Performance
Emily Luisa Hill Ownership Network
Ownership Network List of Emily Luisa Hill
Ownership Network Relation of Emily Luisa Hill
Emily Luisa Hill Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
Emily Luisa Hill is the Chief Financial Officer of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Development Officer Matthew B. Klein .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, Emily Luisa Hill made no insider transaction in PTC Therapeutics Inc (PTCT). Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,039 shares made by Eric Pauwels , a net sale of 22,455 shares made by Matthew B. Klein , and a net sale of 2,701 shares made by Lee Scott Golden .
In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 137,302 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 129,602 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
Emily Luisa Hill Mailing Address
Above is the net worth, insider trading, and ownership report for Emily Luisa Hill. You might contact Emily Luisa Hill via mailing address: C/o Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield Nj 07080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
